Let me be the one to put the controversy here to rest....
Gilead has a patent on Sofusbuvir, Harvoni and Epclusa in the USA and some other countries. That means that the insurance companies and whatever government agencies that must abide by the patents can only purchase from Gilead.
Generics are available for importation to many countries. Only the individual, with his own money in hand, has the opportunity to buy these meds and save his life. So if Trump bans Generics, that means everyone has just one option.
If Trump imposes a tariff on generics, that only affects drugs not under patent. Sofusbuvir, Harvoni and Epclusa have 20 year patents in USA.
Let me just add that I don't believe that Trump will do anything to affect drug pricing. But it would be easier to get changes to generic importation laws than to patent laws, which would affect many other industries and products. They are not going to change the patent laws, trust me. Because that would mean knockoffs of Microsoft Windows, Boeing Airliners, Intel chips, etc. is all okay.
So under this scenario, a change to the ability to import generics means you must buy from Gilead.
Therefore, for any Hep C patient not being treated, the Fat lady is singing, time to saddle up and ride.
for generic Epclusa or Harvoni
Gt 1a, F0, VL 6.5 million, AST 59, ALT 62
Started Twinvir 1/15/16
6 wk. labs VL UND, AST 27, ALT 20
EOT labs VL UND, AST 23, ALT 19
SVR 16, VL UND, AST 28, ALT 17
SVR 24 , VL UND, 10/8/16
SVR 125, VL UND, 9/22/18
SVR 230, VL UND, 10/3/20